Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis
Abstract Background Myosteatosis has been reported to be a novel biomarker that could predict survival outcomes in patients with colorectal cancer. However, results have been conflicting. This systematic review and meta‐analysis aimed to evaluate the long‐term impact of myosteatosis on the survival...
Main Authors: | Chan Mi Lee, Jeonghyun Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Journal of Cachexia, Sarcopenia and Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1002/jcsm.12575 |
Similar Items
-
Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer
by: Yerim Kim, et al.
Published: (2023-04-01) -
Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer
by: In Kyu Park, et al.
Published: (2021-12-01) -
Combined impact of myosteatosis and liver steatosis on prognosis in stage I–III colorectal cancer patients
by: Dong Hee Lee, et al.
Published: (2023-12-01) -
Quality Matters as Much as Quantity of Skeletal Muscle: Clinical Implications of Myosteatosis in Cardiometabolic Health
by: Hong-Kyu Kim, et al.
Published: (2021-12-01) -
The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis
by: Eleni Geladari, et al.
Published: (2023-05-01)